• About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
    • Intellia’s Journey
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Full-Spectrum Approach
    • Scientific Publications & Presentations
    • Glossary
  • Programs & Pipelines
    • Pipeline
    • Clinical Trials
  • Patient Stories
    • Patient Stories
    • Disease Focus
      • Overview
      • Transthyretin Amyloidosis
      • Hereditary Angioedema
      • Alpha-1 Antitrypsin Deficiency
      • Hodgkin Lymphoma
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Full-Spectrum Blog
  • Contact
Intellia Therapeutics
  • Full-Spectrum Blog
  • Contact
  • About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
    • Intellia’s Journey
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Full-Spectrum Approach
    • Scientific Publications &
      Presentations
    • Glossary
  • Programs & Pipelines
    • Pipeline
    • Clinical Trials
  • Patient Focus
    • Patient Stories
    • Disease Focus
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications &
      Presentations
    • Corporate Deck
    • Events & Presentations
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Stock Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
Disease Focus

Disease Focus

  • Patient Stories
  • Disease Focus

At Intellia, we focus on identifying opportunities that can positively transform the lives of people living with severe and life-threatening conditions. Learn more about the diseases we’re investigating.

Transthyretin Amyloidosis

Transthyretin Amyloidosis

Transthyretin amyloidosis is a rare, rapidly progressive disease caused by a build-up of misfolded transthyretin proteins produced by the liver.

Learn More
Hereditary Angioedema

Hereditary Angioedema

Hereditary angioedema is a rare, hereditary condition associated with frequent episodes or attacks of painful swelling in various parts of the body.

Learn More
Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin (AAT) deficiency is a genetic disease in which the body does not make enough AAT, a protein that protects the lungs and liver.

Learn More
Hodgkin Lymphoma

Hodgkin Lymphoma

Hodgkin lymphoma (HL) is a cancer of the lymphatic system, which is part of the immune system. HL starts when there is a change to the DNA of a white blood cell, known as a lymphocyte.

Learn More
  • Cookie Policy
  • Terms of Use
  • Privacy Policy

© Intellia Therapeutics, Inc. 2023

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.

You are leaving the
Intellia Therapeutics, Inc. website.

You may return to the Intellia Therapeutics, Inc. website by closing the window to the third-party website you have opened. Do you wish to continue?

When you are ready to return to the Intellia Therapeutics, Inc. website, simply close the window to the third-party website you have opened.

Yes No